Literature DB >> 34162344

Predictors of aetiology and outcomes of acute gastrointestinal illness in returning travellers: a retrospective cohort analysis.

Louis Tapper1, Sophie Skarbek1, Robert A Lever2,3, Peter L Chiodini4,5, Margaret Armstrong4, Robin L Bailey4,5.   

Abstract

BACKGROUND: Gastrointestinal illness is a major cause of morbidity in travellers and is a common reason for presentation to healthcare services on return. Whilst the aetiology of imported gastrointestinal disease is predominantly infectious, outcomes are variable due to a range of phenomena such as post-infectious irritable bowel syndrome, drug resistance and occult pathology (both infectious and non-infectious). Previous studies have focussed on predictors of aetiology of gastrointestinal disease in travellers; we present a retrospective study combining both aetiological and early outcome data in a large cohort of returned travellers.
METHOD: We identified 1450 patients who attended our post-travel walk-in clinic with gastrointestinal symptoms between 2010 and 2016. Demographic, travel, clinical and laboratory data was collected through case note review. Logistic regression analysis to examine correlates of aetiology and outcome were performed in R (CRAN Project 2017).
RESULTS: Of 1450 patients in our cohort 153 reported bloody diarrhoea and 1081 (74.6%) reported non-bloody diarrhoea. A definitive microbiological diagnosis was made in 310 (20.8%) of which 137 (9.4%) had a parasite identified and 111 (7.7%) had a bacterial cause identified. Factors associated with a parasitological diagnosis included history of travel to South Asia (aOR = 2.55; 95%CI 1.75-3.70, p < 0.0001) and absence of bloody diarrhoea (aOR = 0.22; 95%CI 0.066-0.53, p < 0.005). Factors associated with a bacteriological diagnosis included male gender (aOR = 1.69; 95%CI 1.10-2.62, p < 0.05), an age < 37 years on presentation (aOR = 2.04; 95%CI 1.25-3.43, p < 0.01), white cells on stool microscopy (aOR = 3.52; 95%CI 2.09-5.86, p < 0.0001) and a C-reactive protein level of >5iu/dL (aOR = 4.68; 95%CI 2.91-7.72, p < 0.0001). The majority (1235/1450, 82.6%) reported full symptomatic resolution by the first follow up visit; factors associated with lack of symptomatic resolution included female gender (aOR = 1.45 95%CI 1.06-1.99, p < 0.05), dysenteric diarrhoea (aOR = 2.14 (95%CI 1.38-3.25, p < 0.0005) and elevated peripheral leukocyte count (aOR = 1.58 95%CI 1.02-2.40, p < 0.05).
CONCLUSIONS: In a cohort of returned travellers, we were able to identify multiple factors that are correlated with both aetiology and outcome of imported gastrointestinal syndromes. We predict these data will be valuable in the development of diagnostic and therapeutic pathways for patients with imported gastrointestinal infections.

Entities:  

Keywords:  Diarrhoea; Gastrointestinal illness; Parasitic disease; Returning travellers

Year:  2021        PMID: 34162344     DOI: 10.1186/s12879-021-06223-3

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  13 in total

1.  Practice guidelines for the management of infectious diarrhea.

Authors:  R L Guerrant; T Van Gilder; T S Steiner; N M Thielman; L Slutsker; R V Tauxe; T Hennessy; P M Griffin; H DuPont; R B Sack; P Tarr; M Neill; I Nachamkin; L B Reller; M T Osterholm; M L Bennish; L K Pickering
Journal:  Clin Infect Dis       Date:  2001-01-30       Impact factor: 9.079

Review 2.  Global etiology of travelers' diarrhea: systematic review from 1973 to the present.

Authors:  Nipam Shah; Herbert L DuPont; David J Ramsey
Journal:  Am J Trop Med Hyg       Date:  2009-04       Impact factor: 2.345

Review 3.  Traveler's diarrhea: a clinical review.

Authors:  Robert Steffen; David R Hill; Herbert L DuPont
Journal:  JAMA       Date:  2015-01-06       Impact factor: 56.272

4.  Irritable bowel syndrome among a cohort of European travelers to resource-limited destinations.

Authors:  Raffaela Pitzurra; Michael Fried; Gerhard Rogler; Christina Rammert; Alois Tschopp; Christoph Hatz; Robert Steffen; Margot Mutsch
Journal:  J Travel Med       Date:  2011-06-15       Impact factor: 8.490

Review 5.  Enteropathogens and chronic illness in returning travelers.

Authors:  Allen G P Ross; G Richard Olds; Allan W Cripps; Jeremy J Farrar; Donald P McManus
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

6.  Geographic, symptomatic and laboratory predictors of parasitic and bacterial causes of diarrhoea in travellers.

Authors:  Alastair C McGregor; Christopher J M Whitty; Stephen G Wright
Journal:  Trans R Soc Trop Med Hyg       Date:  2012-07-20       Impact factor: 2.184

7.  Post-infectious sequelae of travelers' diarrhea: irritable bowel syndrome.

Authors:  Margot Mutsch; Raffaela Pitzurra; Christoph Hatz; Robert Steffen
Journal:  J Travel Med       Date:  2014 Mar-Apr       Impact factor: 8.490

8.  Illness in children after international travel: analysis from the GeoSentinel Surveillance Network.

Authors:  Stefan Hagmann; Richard Neugebauer; Eli Schwartz; Cecilia Perret; Francesco Castelli; Elizabeth D Barnett; William M Stauffer
Journal:  Pediatrics       Date:  2010-04-05       Impact factor: 7.124

9.  Travel and travelers' diarrhea in patients with irritable bowel syndrome.

Authors:  Herbert L DuPont; Greg Galler; Francisco Garcia-Torres; Andrew W Dupont; Anthony Greisinger; Zhi-Dong Jiang
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

10.  Gastrointestinal infection among international travelers globally.

Authors:  Zoe Greenwood; James Black; Leisa Weld; Daniel O'Brien; Karin Leder; Frank Von Sonnenburg; Prativa Pandey; Eli Schwartz; Bradley A Connor; Graham Brown; David O Freedman; Joseph Torresi
Journal:  J Travel Med       Date:  2008 Jul-Aug       Impact factor: 8.490

View more
  1 in total

1.  Weather variables as important clinical predictors of bacterial diarrhoea among international travellers.

Authors:  Melissa A Pender; Timothy Smith; Ben J Brintz; Prativa Pandey; Sanjaya K Shrestha; Sinn Anuras; Samandra Demons; Siriporn Sornsakrin; Ladaporn Bodhidatta; James A Platts-Mills; Daniel T Leung
Journal:  J Travel Med       Date:  2022-07-14       Impact factor: 39.194

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.